Editorial: Growth hormone therapy in childhood: Titration versus weight-based dosing?

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 7, 2007, Pages 2436-2438

  Baron, Jeffrey ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN;

BODY HEIGHT; BODY WEIGHT; DRUG DOSE REGIMEN; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; GROWTH HORMONE DEFICIENCY; HORMONAL THERAPY; HUMAN; PREPUBERTY; PRIORITY JOURNAL; RISK ASSESSMENT; SHORT STATURE; TITRIMETRY; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 34447115137     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-0900     Document Type: Editorial

References (25)

1. Kamp GA, Zwinderman AH, Van Doorn J, Hackeng W, Frolich M, Schonau E, Wit JM 2002 Biochemical markers of growth hormone (GH) sensitivity in children with idiopathic short stature: individual capacity of IGF-I generation after high-dose GH treatment determines the growth response to GH. Clin Endocrinol (Oxf) 57:315-325
2. Salmon Jr WD, Daughaday WH 1957 A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med 49:825-836
3. van der Eerden BC, Karperien M, Wit JM 2003 Systemic and local regulation of the growth plate. Endocr Rev 24:782-801
4. Mauras N, Haymond MW 2005 Are the metabolic effects of GH and IGF-I separable? Growth Horm IGF Res 15:19-27
5. Wang J, Zhou J, Cheng CM, Kopchick JJ, Bondy CA 2004 Evidence supporting dual, IGF-I-independent and IGF-I-dependent, roles for GH in promoting longitudinal bone growth. J Endocrinol 180:247-255
6. Rosenfeld RG 2005 The molecular basis of idiopathic short stature. Growth Horm IGF Res 15(Suppl A):S3-S5
7. Nwosu BU, Coco M, Jones J, Barnes KM, Yanovski JA, Baron J 2004 Short stature with normal growth hormone stimulation testing: lack of evidence for partial growth hormone deficiency or insensitivity. Horm Res 62:97-102
8. Han JC, Balagopal P, Sweeten S, Darmaun D, Mauras N 2006 Evidence for hypermetabolism in boys with constitutional delay of growth and maturation. J Clin Endocrinol Metab 91:2081-2086
9. Solans CV, Lifshitz F 1992 Body weight progression and nutritional status of patients with familial short stature with and without constitutional delay in growth. Am J Dis Child 146:296-302
10. Wudy SA, Hagemann S, Dempfle A, Ringler G, Blum WF, Berthold LD, Alzen G, Gortner L, Hebebrand J 2005 Children with idiopathic short stature are poor eaters and have decreased body mass index. Pediatrics 116:e52-e57
11. Olney RC, Bukulmez H, Bartels CF, Prickett TC, Espiner EA, Potter LR, Warman ML 2006 Heterozygous mutations in natriuretic peptide receptor-B (NPR2) are associated with short stature. J Clin Endocrinol Metab 91:1229-1232
12. Heinrichs C, Colli M, Yanovski JA, Laue L, Gerstl NA, Kramer AD, Uyeda JA, Baron J 1997 Effects of fasting on the growth plate: systemic and local mechanisms. Endocrinology 138:5359-5365
13. Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Shalet SM, Vance ML 2006 Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline. Endocrine Society's Clinical Guidelines Subcommittee. J Clin Endocrinol Metab 91:1621-1634
14. Johannsson G, Rosen T, Bengtsson BA 1997 Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults. Clin Endocrinol (Oxf) 47:571-581
15. Hoffman AR, Strasburger CJ, Zagar A, Blum WF, Kehely A, Hartman ML 2004 Efficacy and tolerability of an individualized dosing regimen for adult growth hormone replacement therapy in comparison with fixed body weightbased dosing. J Clin Endocrinol Metab 89:3224-3233
16. Kriström B, Jansson C, Rosberg S, Albertsson-Wikland K 1997 Growth response to growth hormone (GH) treatment relates to serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in short children with various GH secretion capacities. J Clin Endocrinol Metab 82:2889-2898
17. Cohen P, Rogol AD, Howard CP, Bright GM, Kappelgaard A-M, Rosenfeld RG, on behalf of the American Norditropin Study Group 2007 Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study. J Clin Endocrinol Metab 92:2480-2486
18. Kamp GA, Waelkens JJJ, De Muinck Keizer-Schrama SMPF, Delemarre-van de Waal HA, Verhoeven-Wind L, Wit JM 2002 High dose growth hormone treatment induces acceleration of skeletal maturation and an earlier onset of puberty in children with idiopathic short stature. Arch Dis Child 87:215-220
19. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M 1998 Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279:563-566
20. Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, Stampfer MJ 1999 Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 91:620-625
21. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M 1998 Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351:1393-1396
22. Sandberg DE, Colsman M 2005 Growth hormone treatment of short stature: status of the quality of life rationale. Horm Res 63:275-283
23. Wit JM 2007 Optimizing growth hormone therapy in growth hormone deficient children: what to do in the absence of hard evidence? Horm Res 68:244-247
24. Wilson TA, Rose SR, Cohen P, Rogol AD, Backeljauw P, Brown R, Hardin DS, Kemp SF, Lawson M, Radovick S, Rosenthal SM, Silverman L, Speiser P; The Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee 2003 Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee. J Pediatr 143:415-421
25. Rosenfeld RG 2006 Editorial: the pharmacogenomics of human growth. J Clin Endocrinol Metab 91:795-796